Who makes LTC 25 minutes?

LTC 25 minutes is developed by Netherlands Institute for Pigment Disorders.

What development phase is LTC 25 minutes in?

LTC 25 minutes is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

LTC 25 minutes

Netherlands Institute for Pigment Disorders · FDA-approved active Small molecule Quality 3/100

At a glance

Generic name	LTC 25 minutes
Also known as	Pliaglis cream, Lidocaine 70 mg/g + tetracaine 70 mg/g cream
Sponsor	Netherlands Institute for Pigment Disorders
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Fractional Laser Assisted Delivery of Anesthetics IIIb (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

LTC 25 minutes CI brief — competitive landscape report
LTC 25 minutes updates RSS · CI watch RSS
Netherlands Institute for Pigment Disorders portfolio CI